Lakewood-Amedex Biotherapeutics Inc. (LABT)
Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
0. 61
-0.02
-3.1746%
Pre Market
$
+0.05 +9.0164% 0. 67
1.21M Market Cap
- P/E Ratio
- Div Yield
148,300 Volume
- Eps
$ 0.63
Previous Close Investors:
Want to track LABT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lakewood-Amedex Biotherapeutics Inc. (LABT) Statistics
Valuation metrics
Market Cap 1.21M
Enterprise value -1.11M
Trailing P/E (ttm) -0.08
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.26
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 259.95K
Average volume (90 days) 3.35M
Price summary
52-Week low 0.58
52-Week high 9.82
Beta -
50-Day moving average 1.48
200-Day moving average 2.23
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 22 Jun 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.48%
Return on equity 16.88%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -5.18
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.23
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 7.7%
Book value per share (mrq) 3.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
